Clinical trials
Diabetes Mellitus Risk clinical trials
Below are recruiting diabetes mellitus risk clinical trials, each written for real people, not researchers. We’re tracking 206 recruiting studies, each written for real people, not researchers, below.
Recruiting studies
- NCT05369065RecruitingPhase 1
Artery ablation for type 2 diabetes with kidney and liver arteries
This Phase 1 study tests whether a minimally invasive artery procedure can improve type 2 diabetes and related health problems by targeting kidney and liver blood vessels. Because it’s early-stage, the main goal is safety and learning how the treatment works in people who meet specific diabetes, blood pressure, and blood test requirements.
TbilisiAges 21–65 - NCT06585072Recruiting
Pancreatic cancer and diabetes risk after surgery
This trial studies how pancreatic cancer affects blood sugar and the risk of developing diabetes after surgery. Patients who have their pancreas removed will provide blood and tissue samples to help understand this link.
Shanghai, Shanghai MunicipalityAges 18 years+ - NCT06767774RecruitingPhase 4
Comparing two cholesterol treatments for heart patients
This study compares two different ways of lowering cholesterol: a moderate statin (pitavastatin) plus another drug (ezetimibe) versus a stronger statin alone. The goal is to see which approach is safer regarding the risk of developing new diabetes.
SeoulAges 18 years+ - NCT06973850Enrolling by invitation
Online Foot Care Education for Older Adults with Diabetes
This study tests a nurse-led online education program designed to help older adults with diabetes feel more confident about taking care of their feet and understand the risks of foot problems. You would learn through videos or virtual meetings from home.
Al Mansurah, MansouraAges 60 years+ - NCT07222137RecruitingPhase 3
Baricitinib to delay type 1 diabetes in at-risk people
This trial tests if baricitinib, a pill that calms the immune system, can slow down or delay the onset of type 1 diabetes in children and adults who are at high risk. It is for people whose blood sugar is already starting to rise but who do not yet need insulin.
Santa Barbara, CaliforniaAges 1–35 - NCT06674980Recruiting
Testing placenta-based wound treatment for diabetic and venous leg ulcers
This trial tests if adding a special placenta-based wound covering to standard care helps heal diabetic foot ulcers and venous leg ulcers faster. It's for people with wounds that haven't healed after standard treatment for at least 4 weeks.
Metairie, LouisianaAges 18 years+ - NCT07026539RecruitingPhase 4
Finerenone for heart and kidney health in type 2 diabetes
This trial tests whether adding finerenone to your current diabetes medications can better protect your heart and kidneys. It is for people with type 2 diabetes who already take an SGLT2 inhibitor and an ACE inhibitor or ARB.
Aarhus NAges 18 years+ - NCT07221045Recruiting
Food as medicine for food-insecure families in rural North Carolina
This study tests whether providing fresh produce boxes and nutrition classes helps families in rural North Carolina who struggle with food access. If you are a parent or caregiver of an 8–14-year-old and live in a participating county, you may qualify.
Raleigh, North CarolinaAges 8–64 - NCT06950788Recruiting
Glucose changes in cirrhosis patients around liver transplant
This study looks at how the body processes sugar (glucose) in people with cirrhosis who are waiting for a liver transplant. It aims to track changes in blood sugar control before and after transplant, which may help improve care for patients with liver disease.
Chicago, IllinoisAges 18–75 - NCT06590519Recruiting
Testing date seed extract for diabetes and heart risk
This study tests whether an extract from date seeds might help people with type 2 diabetes better control their blood sugar and lower their risk of heart disease. Participants will take the extract as a supplement, and researchers will track how it affects their diabetes and heart health over time.
Serdang, SelangorAges 18–80 - NCT07747857RecruitingPhase 1
Study of TQF3250 capsules for type 2 diabetes with overweight or obesity
This study tests a new capsule medicine for adults with type 2 diabetes who are overweight or have obesity. The goal is to see if it helps control blood sugar and weight.
Fuzhou, FujianAges 18–70 - NCT07658755Recruiting
LiverSeek: Finding advanced liver scarring in MASLD
This study uses routine blood tests to find people with advanced liver scarring caused by a condition called MASLD. If you are between 50 and 75, have certain metabolic risks, and get blood work from your primary care doctor at select centers, you may be eligible.
Madrid, MadridAges 50–75 - NCT06861062Recruiting
Vitamin D and yeast beta-glucan for type 2 diabetes
This trial tests if taking vitamin D3 and yeast beta-glucan supplements can help control blood sugar and lower heart disease risk in people with type 2 diabetes. It may be an option for those who want to see if supplements can improve their diabetes management.
Nanning, GuangxiAges 40–79 - NCT07307183Recruiting
Predicting foot ulcers risk in diabetes
This study is developing a tool to predict your risk of getting foot ulcers if you have diabetes. By analyzing medical records, the researchers hope to identify people who need extra prevention and care.
JonseredAges 18 years+ - NCT05730582Enrolling by invitation
Improve diabetes screening by using health outreach from records
This trial looks at whether outreach messages sent using your electronic health record can help more adults get diabetes screening. It’s designed for people who are at risk for diabetes but are not already in the clinic’s diabetes registry.
Dallas, TexasAges 18–75 - NCT06959784Enrolling by invitationPhase 4
A study on new diabetes drugs for heart health and remission
This trial tests if newer diabetes medications can reduce heart risk and help achieve diabetes remission in people newly diagnosed with type 2 diabetes. It may be an option if you have not taken diabetes drugs before or stopped them over three months ago, and your blood sugar and weight are in certain ranges.
BeijingAges 30–70 - NCT05752292Enrolling by invitation
Pregnant with gestational diabetes: share risk info to help
This study is testing how to share risk information during pregnancy in a way that helps patients feel more informed and empowered. It includes people currently pregnant with gestational diabetes and will ask about your preferences and understanding.
Pleasanton, CaliforniaAges 18 years+ - NCT07773272Recruiting
Combined heart, kidney, and metabolic care after a heart attack
This study tests a new approach to managing heart, kidney, and metabolic health together after a heart attack or unstable angina. It aims to improve your recovery and reduce future risks.
Heerlen, LimburgAges 18 years+ - NCT07593625Recruiting
Testing a new insulin pump algorithm for type 1 diabetes
This study tests a new automated insulin delivery system to help people with type 1 diabetes better manage their blood sugar. It aims to see if the system improves glucose control safely.
ChristchurchAges 2–70 - NCT06874907Recruiting
Predicting gestational diabetes with a glucose monitor in early pregnancy
This study tests whether wearing a continuous glucose monitor (a small sensor on your skin) in early pregnancy can help predict if you will develop gestational diabetes later. The goal is to catch it early so you and your baby get the best care possible.
El Palmar, MurciaAges 18 years+ - NCT07355270Recruiting
Radiofrequency vapor ablation for type 2 diabetes
This trial tests a new device that uses radiofrequency energy to treat the lining of the upper small intestine in people with type 2 diabetes. The goal is to see if this treatment is safe and helps improve blood sugar control.
Scottsdale, ArizonaAges 22–65 - NCT06525259Recruiting
Study on risk factors for type 2 diabetes in youth
This study looks for children and teens who are at high risk of developing type 2 diabetes to understand what factors lead to it. If your child is overweight, has slightly high blood sugar, and is in early to mid-puberty, they may be able to join.
Birmingham, AlabamaAges 8–15 - NCT07468474Recruiting
Finding Type 1 Diabetes Risk and Offering Education
This study is designed to help identify and monitor people at high risk for type 1 diabetes. It involves education and regular check-ups to better understand and manage the condition.
Beijing, Beijing MunicipalityAges 4 years+ - NCT05579626Enrolling by invitationPhase 4
Low-dose statin plus ezetimibe vs high-dose statin for prediabetes
This trial compares two cholesterol-lowering approaches in people with prediabetes to see which one is less likely to lead to new-onset diabetes. It may help you choose a safer medication plan if you need strong cholesterol treatment to prevent future heart problems.
Bucheon-siAges 18–75
Hear when a new Diabetes Mellitus Risk trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.
Common questions
- Are there clinical trials for diabetes mellitus risk?
- Yes. Clin2 currently lists 206 recruiting diabetes mellitus risk studies from the U.S. registry, each rewritten for real people, not researchers, so you can see what it’s testing and who it’s for.
- How do I know if I qualify for a diabetes mellitus risk trial?
- Each study lists its eligibility criteria — rules about age, diagnosis, and prior treatments. On every Clin2 trial page we explain these in words written for real people and offer a short, optional pre-screen for a fit read. The study team makes the final decision.
- Does it cost anything to join a diabetes mellitus risk trial?
- Using Clin2 is always free. Many trials cover the cost of the study treatment and related visits; some reimburse travel. The study team explains exactly what’s covered before you decide.
Related conditions
Clin2 helps you find and understand clinical trials and does not provide medical advice. Study data comes from ClinicalTrials.gov. Talk with your doctor about whether a specific trial is right for you.